The upregulation of LOX/LOXLs seems to be a feature of several fibrotic processes affecting the heart, from those associated to post-MI cardiac remodeling, cardiac hypertrophy triggered by pressure or volume overload, HFPEF associated with obesity and metabolic syndrome or AF. Here, LOX is linked to atrial fibrillation.